Erythromycin Dosing Regimen
For adults, erythromycin should be dosed at 500 mg orally four times daily (or 250 mg four times daily for less severe infections), and for children 40-50 mg/kg/day divided into four doses, with duration and adjustments varying by indication. 1
Standard Adult Dosing
The FDA-approved regimen for adults is 1:
- Standard dose: 250 mg four times daily in equally spaced doses, OR 500 mg every 12 hours
- Severe infections: Up to 4 g per day in divided doses
- Optimal absorption: Take on empty stomach (at least 30 minutes, preferably 2 hours before meals), though can be taken with food if GI intolerance occurs
Standard Pediatric Dosing
For children, the usual dosage is 1:
- 30-50 mg/kg/day in equally divided doses
- Severe infections: May double the dose but should not exceed 4 g per day
- Age, weight, and infection severity determine the proper dosage
Indication-Specific Regimens
Pertussis (Treatment and Prophylaxis)
The CDC guidelines recommend a 14-day course due to reported relapses with shorter durations 2:
- Infants <1 month: NOT preferred due to infantile hypertrophic pyloric stenosis (IHPS) risk; use azithromycin instead. If erythromycin must be used: 40-50 mg/kg/day in 4 divided doses with close IHPS monitoring
- Infants >1 month and children: 40-50 mg/kg/day (maximum 2 g/day) in 4 divided doses for 14 days
- Adults: 2 g/day in 4 divided doses for 14 days
Critical caveat: In one cohort study, 7 out of 157 neonates (5%) developed IHPS after erythromycin prophylaxis, with risk increasing to 10% for 15-21 day courses 1. Parents must be counseled to report vomiting or feeding irritability immediately.
Chlamydia trachomatis Infections
Urogenital infections in adults (when tetracycline contraindicated) 3, 1:
- 500 mg four times daily for at least 7 days
- Alternative for pregnant women who cannot tolerate this: 500 mg every 12 hours OR 250 mg four times daily for at least 14 days
Neonatal conjunctivitis 1:
- 50 mg/kg/day in 4 divided doses for at least 2 weeks
Pneumonia of infancy 1:
- 50 mg/kg/day in 4 divided doses for at least 3 weeks
Streptococcal Infections
- Upper respiratory tract infections: Therapeutic dosage for at least 10 days 1
- Long-term rheumatic fever prophylaxis: 250 mg twice daily 1
Other Indications
- Intestinal amebiasis: Adults 500 mg every 12 hours or 250 mg every 6 hours for 10-14 days; Children 30-50 mg/kg/day in divided doses for 10-14 days 1
- Legionnaires' Disease: 1-4 g daily in divided doses (optimal dosage not established) 1
Hepatic Impairment Adjustments
Erythromycin is principally excreted by the liver, requiring caution in hepatic impairment 1. Research demonstrates that patients with alcoholic liver disease have a significantly prolonged elimination half-life (3.2 hours vs 2.0 hours in normal subjects) 4. However, this difference does not require routine dosage adjustment 4.
The FDA label states to "exercise caution" but provides no specific dose reduction guidelines 1. In clinical practice, monitor for adverse effects more closely and consider empirically reducing to the lower end of dosing ranges in severe hepatic dysfunction.
Route of Administration
Erythromycin is available in multiple oral formulations 2, 1:
- Erythromycin base (tablets, capsules)
- Erythromycin stearate (tablets)
- Erythromycin ethylsuccinate (tablets, powders, liquids)
The estolate salt achieves higher tissue concentrations than ethylsuccinate, allowing for lower daily doses (20-30 mg/kg/day vs 40 mg/kg/day) 5, 6. Enteric-coated tablets and ester derivatives can be taken with food to minimize GI side effects 1.
Key Clinical Pitfalls
GI intolerance is dose-related and the most common adverse effect 2, 1. Strategies to improve tolerance include: limiting daily doses to <4 g, temporarily decreasing dose, using small frequent doses of liquid suspension, taking with milk/food, and drinking water every 15 minutes after doses 7.
Drug interactions are extensive 1: Never co-administer with astemizole, cisapride, pimozide, or terfenadine 2. Monitor closely with theophylline (may increase levels by 35%), digoxin, verapamil, and other CYP450-metabolized drugs.
IHPS risk in neonates is substantial and dose-dependent 2, 1. Azithromycin is strongly preferred for infants <1 month.
Twice-daily dosing is NOT recommended when doses >1 g daily are needed 1.
Cardiovascular risks include QT prolongation and torsades de pointes, particularly with drug interactions 8.